 BRYAN, Texas, Sept. 07, 2021 GLOBE NEWSWIRE -- iBio, Inc. NYSEA:IBIO iBio or the Company, a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System, today announced that it will participate in the H.C. Wainwright 23rd Annual Global Investment Conference, to be held virtually September 13-15, 2021. 